Want to see SE:SEDANA full AI Analyst Report?
Sedana Medical AB (SEDANA) Ratios
Sedana Medical AB Ratios
SE:SEDANA's free cash flow for Q3 2026 was $-3.33M. For the 2026 fiscal year, SE:SEDANA's free cash flow was decreased by $-358.00K and operating cash flow was $-2.98M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.40 | 5.39 | 10.68 | 13.78 | 14.33 |
| Quick Ratio | 2.66 | 4.50 | 9.68 | 12.99 | 14.14 |
| Cash Ratio | 1.78 | 3.76 | 5.37 | 12.44 | 13.60 |
| Solvency Ratio | -0.69 | -0.08 | -1.19 | -1.25 | -0.76 |
| Operating Cash Flow Ratio | -0.25 | -0.23 | -0.88 | -2.36 | -0.67 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -3.53 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 120.07M | $ 217.03M | $ 415.56M | $ 620.98M | $ 814.62M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.06 | 1.06 | 1.05 | 1.05 | 1.06 |
| Debt Service Coverage Ratio | -8.32 | -1.36 | -243.10 | -256.65 | -204.51 |
| Interest Coverage Ratio | -22.12 | -285.21 | -304.87 | -407.58 | -251.84 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.06 | 0.06 | 0.05 | 0.09 | 0.10 |
| Net Debt to EBITDA | 8.53 | 46.61 | 4.39 | 9.23 | 16.85 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.27% | 70.57% | 70.83% | 70.06% | 67.05% |
| EBIT Margin | -16.06% | -5.47% | -38.22% | -59.15% | -35.90% |
| EBITDA Margin | -5.05% | -2.26% | -33.58% | -52.80% | -30.85% |
| Operating Profit Margin | -16.06% | -28.40% | -42.60% | -84.59% | -38.45% |
| Pretax Profit Margin | -28.60% | -5.57% | -38.36% | -59.36% | -36.05% |
| Net Profit Margin | -29.59% | -5.97% | -38.74% | -59.83% | -36.42% |
| Continuous Operations Profit Margin | -29.59% | -5.97% | -38.74% | -59.83% | -36.42% |
| Net Income Per EBT | 103.46% | 107.30% | 101.00% | 100.79% | 101.04% |
| EBT Per EBIT | 178.08% | 19.60% | 90.04% | 70.17% | 93.75% |
| Return on Assets (ROA) | -6.21% | -1.05% | -5.88% | -6.80% | -4.96% |
| Return on Equity (ROE) | -6.58% | -1.11% | -6.15% | -7.14% | -5.26% |
| Return on Capital Employed (ROCE) | -3.56% | -5.25% | -6.75% | -10.06% | -5.53% |
| Return on Invested Capital (ROIC) | -3.55% | -5.21% | -6.73% | -10.01% | -5.51% |
| Return on Tangible Assets | -32.15% | -3.69% | -12.74% | -10.68% | -6.46% |
| Earnings Yield | -5.80% | -0.56% | -2.46% | -3.96% | -0.64% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.90 | 5.45 | 4.51 | 4.63 | 4.81 |
| Payables Turnover | 10.91 | 8.84 | 8.68 | 3.26 | 3.49 |
| Inventory Turnover | 1.52 | 1.15 | 1.04 | 0.95 | 4.73 |
| Fixed Asset Turnover | 20.51 | 16.82 | 18.48 | 8.35 | 9.48 |
| Asset Turnover | 0.21 | 0.18 | 0.15 | 0.11 | 0.14 |
| Working Capital Turnover Ratio | 1.15 | 0.56 | 0.30 | 0.17 | 0.27 |
| Cash Conversion Cycle | 281.40 | 341.81 | 388.33 | 350.02 | 48.37 |
| Days of Sales Outstanding | 74.53 | 67.03 | 80.90 | 78.91 | 75.81 |
| Days of Inventory Outstanding | 240.30 | 316.08 | 349.46 | 382.92 | 77.20 |
| Days of Payables Outstanding | 33.44 | 41.30 | 42.03 | 111.81 | 104.64 |
| Operating Cycle | 314.84 | 383.11 | 430.36 | 461.83 | 153.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.13 | -0.12 | -0.38 | -1.16 | -0.44 |
| Free Cash Flow Per Share | -0.76 | -1.88 | -2.08 | -2.55 | -1.63 |
| Dividend Paid and CapEx Coverage Ratio | -0.20 | -0.07 | -0.23 | -0.84 | -0.37 |
| Capital Expenditure Coverage Ratio | -0.20 | -0.07 | -0.23 | -0.84 | -0.37 |
| Operating Cash Flow Coverage Ratio | -2.72 | -1.99 | -8.84 | -13.20 | -4.65 |
| Operating Cash Flow to Sales Ratio | -0.06 | -0.07 | -0.25 | -0.94 | -0.26 |
| Free Cash Flow Yield | -7.36% | -9.85% | -8.55% | -13.63% | -1.67% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.13 | -173.45 | -40.59 | -25.27 | -156.93 |
| Price-to-Sales (P/S) Ratio | 5.10 | 10.60 | 15.73 | 15.12 | 57.16 |
| Price-to-Book (P/B) Ratio | 1.13 | 1.98 | 2.49 | 1.80 | 8.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.58 | -10.15 | -11.69 | -7.34 | -60.05 |
| Price-to-Operating Cash Flow Ratio | -79.91 | -161.05 | -63.58 | -16.09 | -220.68 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | 2.12 | 2.15 | -1.31 | -1.47 |
| Enterprise Value Multiple | -92.41 | -423.23 | -42.44 | -19.40 | -168.41 |
| Enterprise Value | 934.90M | 1.71B | 2.19B | 1.26B | 8.27B |
| EV to EBITDA | -92.41 | -423.23 | -42.44 | -19.40 | -168.41 |
| EV to Sales | 4.67 | 9.55 | 14.25 | 10.24 | 51.96 |
| EV to Free Cash Flow | -12.43 | -9.14 | -10.60 | -4.97 | -54.59 |
| EV to Operating Cash Flow | -73.16 | -145.07 | -57.62 | -10.90 | -200.61 |
| Tangible Book Value Per Share | 1.31 | 2.29 | 4.27 | 6.40 | 8.96 |
| Shareholders’ Equity Per Share | 9.07 | 9.65 | 9.76 | 10.36 | 11.87 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.03 | -0.07 | -0.01 | -0.01 | -0.01 |
| Revenue Per Share | 2.02 | 1.80 | 1.55 | 1.24 | 1.72 |
| Net Income Per Share | -0.60 | -0.11 | -0.60 | -0.74 | -0.62 |
| Tax Burden | 1.03 | 1.07 | 1.01 | 1.01 | 1.01 |
| Interest Burden | 1.78 | 1.02 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.10 | 0.11 | 0.14 | 0.16 | 0.12 |
| SG&A to Revenue | 0.77 | 0.88 | 0.31 | 0.47 | 0.33 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.40 | 0.23 | 0.64 | 1.09 | 0.67 |
Currency in SEK
